Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | International Journal of COPD | journal | 1.272 Q1 | 88 | 74 | 181 | 3080 | 553 | 176 | 2.96 | 41.62 | 30.70 | |
2 | International Journal of Nanomedicine | journal | 1.211 Q1 | 179 | 332 | 199 | 1316 | 910 | 197 | 2.97 | 3.96 | 37.90 | |
3 | Vascular Health and Risk Management | journal | 0.859 Q1 | 82 | 92 | 384 | 3863 | 1262 | 381 | 3.06 | 41.99 | 30.83 | |
4 | Perspectives in Medicinal Chemistry | journal | 0.785 Q2 | 17 | 2 | 13 | 81 | 36 | 13 | 4.50 | 40.50 | 0.00 | |
5 | Clinical Epidemiology | journal | 0.686 Q3 | 78 | 44 | 35 | 1657 | 66 | 34 | 1.89 | 37.66 | 35.62 | |
6 | Clinical Interventions in Aging | journal | 0.672 Q2 | 104 | 39 | 171 | 1592 | 558 | 169 | 3.11 | 40.82 | 44.44 | |
7 | Neuropsychiatric Disease and Treatment | journal | 0.652 Q2 | 91 | 82 | 213 | 4256 | 554 | 193 | 2.91 | 51.90 | 34.06 | |
8 | Biologics: Targets and Therapy | journal | 0.645 Q2 | 47 | 7 | 149 | 456 | 323 | 149 | 2.68 | 65.14 | 36.00 | |
9 | OncoTargets and Therapy | journal | 0.588 Q2 | 86 | 19 | 45 | 1125 | 90 | 45 | 2.00 | 59.21 | 25.56 | |
10 | Cancer Informatics | journal | 0.585 Q2 | 37 | 22 | 90 | 806 | 122 | 86 | 1.16 | 36.64 | 27.50 | |
11 | Therapeutics and Clinical Risk Management | journal | 0.540 Q2 | 70 | 8 | 265 | 353 | 630 | 264 | 2.71 | 44.13 | 36.36 | |
12 | Biomarker Insights | journal | 0.525 Q2 | 40 | 17 | 82 | 571 | 148 | 81 | 2.64 | 33.59 | 35.63 | |
13 | Stem Cells and Cloning: Advances and Applications | journal | 0.509 Q2 | 27 | 7 | 14 | 493 | 11 | 13 | 0.79 | 70.43 | 41.18 | |
14 | Clinical Ophthalmology | journal | 0.476 Q3 | 78 | 293 | 321 | 6826 | 429 | 319 | 1.34 | 23.30 | 29.25 | |
15 | Patient Preference and Adherence | journal | 0.454 Q2 | 67 | 71 | 120 | 2594 | 187 | 119 | 1.69 | 36.54 | 46.67 | |
16 | Fluoride - Quarterly Reports | journal | 0.367 Q3 | 51 | 34 | 138 | 791 | 126 | 131 | 0.81 | 23.26 | 41.11 | |
17 | Cancer Management and Research | journal | 0.324 Q3 | 67 | 31 | 32 | 1772 | 51 | 32 | 1.59 | 57.16 | 36.70 | |
18 | Journal of Inflammation Research | journal | 0.316 Q3 | 51 | 13 | 15 | 958 | 7 | 15 | 0.47 | 73.69 | 45.45 | |
19 | International Journal of Women's Health | journal | 0.293 Q2 | 64 | 53 | 69 | 2175 | 104 | 68 | 1.51 | 41.04 | 50.50 | |
20 | Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | journal | 0.271 Q3 | 27 | 11 | 14 | 365 | 14 | 14 | 1.00 | 33.18 | 34.69 | |
21 | HIV/AIDS - Research and Palliative Care | journal | 0.269 Q3 | 32 | 15 | 14 | 813 | 4 | 14 | 0.29 | 54.20 | 39.62 | |
22 | Breast Cancer: Basic and Clinical Research | journal | 0.263 Q3 | 35 | 23 | 23 | 1030 | 24 | 21 | 1.04 | 44.78 | 46.32 | |
23 | Breast Cancer: Targets and Therapy | journal | 0.254 Q3 | 43 | 17 | 9 | 825 | 7 | 9 | 0.78 | 48.53 | 36.59 | |
24 | Clinical Medicine Insights: Oncology | journal | 0.253 Q3 | 33 | 32 | 105 | 2304 | 66 | 102 | 1.55 | 72.00 | 28.26 | |
25 | Journal of Pain Research | journal | 0.250 Q2 | 71 | 44 | 25 | 1610 | 34 | 25 | 1.36 | 36.59 | 37.16 | |
26 | International Journal of General Medicine (discontinued) | journal | 0.247 Q3 | 52 | 35 | 89 | 1073 | 89 | 88 | 1.00 | 30.66 | 34.48 | |
27 | Cell Health and Cytoskeleton | journal | 0.241 Q3 | 16 | 4 | 7 | 218 | 4 | 7 | 0.57 | 54.50 | 40.00 | |
28 | Core Evidence (discontinued) | journal | 0.237 Q1 | 29 | 7 | 49 | 314 | 63 | 47 | 1.84 | 44.86 | 50.00 | |
29 | Clinical Medicine Insights: Blood Disorders | journal | 0.236 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
30 | Open Access Rheumatology: Research and Reviews | journal | 0.225 Q3 | 23 | 8 | 23 | 594 | 11 | 21 | 0.48 | 74.25 | 22.73 | |
31 | Virus Adaptation and Treatment | journal | 0.188 Q3 | 12 | 9 | 15 | 956 | 9 | 15 | 0.60 | 106.22 | 35.00 | |
32 | Journal of Asthma and Allergy | journal | 0.184 Q3 | 41 | 11 | 38 | 520 | 21 | 38 | 0.50 | 47.27 | 52.27 | |
33 | Integrated Blood Pressure Control | journal | 0.175 Q3 | 28 | 2 | 7 | 162 | 3 | 7 | 0.43 | 81.00 | 60.00 | |
34 | Open Access Journal of Clinical Trials | journal | 0.172 Q3 | 15 | 12 | 22 | 266 | 19 | 22 | 0.86 | 22.17 | 20.00 | |
35 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.168 Q3 | 64 | 15 | 36 | 640 | 26 | 35 | 0.72 | 42.67 | 39.02 | |
36 | Risk Management and Healthcare Policy | journal | 0.166 Q3 | 45 | 12 | 10 | 551 | 8 | 10 | 0.80 | 45.92 | 42.86 | |
37 | Clinical, Cosmetic and Investigational Dermatology | journal | 0.165 Q3 | 54 | 4 | 24 | 139 | 11 | 23 | 0.46 | 34.75 | 46.67 | |
38 | Drug, Healthcare and Patient Safety | journal | 0.165 Q4 | 30 | 16 | 35 | 598 | 22 | 33 | 0.63 | 37.38 | 33.33 | |
39 | Clinical Medicine Insights: Cardiology | journal | 0.164 Q3 | 33 | 16 | 37 | 530 | 11 | 34 | 0.30 | 33.13 | 25.71 | |
40 | Clinical and Experimental Gastroenterology | journal | 0.157 Q3 | 45 | 31 | 25 | 2064 | 12 | 25 | 0.48 | 66.58 | 22.13 | |
41 | Immunology and Immunogenetics Insights | journal | 0.157 Q4 | 7 | 1 | 8 | 48 | 6 | 8 | 0.75 | 48.00 | 50.00 | |
42 | Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | journal | 0.153 Q3 | 22 | 13 | 8 | 598 | 5 | 8 | 0.63 | 46.00 | 41.67 | |
43 | Application of Clinical Genetics | journal | 0.151 Q4 | 40 | 13 | 9 | 1250 | 7 | 9 | 0.86 | 96.15 | 44.44 | |
44 | Translational Oncogenomics | journal | 0.147 Q3 | 11 | 0 | 11 | 0 | 4 | 11 | 1.00 | 0.00 | 0.00 | |
45 | Reports in Medical Imaging | journal | 0.141 Q4 | 10 | 6 | 13 | 232 | 3 | 13 | 0.23 | 38.67 | 16.67 | |
46 | Integrative Medicine Insights | journal | 0.135 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
47 | International Journal of Interferon, Cytokine and Mediator Research | journal | 0.126 Q4 | 14 | 10 | 15 | 553 | 3 | 15 | 0.20 | 55.30 | 54.05 | |
48 | Infection and Drug Resistance | journal | 0.123 Q4 | 65 | 24 | 9 | 1292 | 2 | 8 | 0.22 | 53.83 | 37.93 | |
49 | International Journal of Nephrology and Renovascular Disease | journal | 0.122 Q4 | 39 | 18 | 29 | 923 | 6 | 28 | 0.21 | 51.28 | 19.05 | |
50 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 23 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®